Tag: IPCA Laboratories Ltd

IPCA Laboratories

IPCA Laboratories Ltd launches Diulcus® to address Diabetic Foot Ulcer in India

up18news

Diulcus®, developed by NovaLead Pharma, shows promising results in clinical trials with a 77.20% ulcer closure rate New Delhi [India], August 27: As per the ICMR-INDIAB (2023) study, 10 crore people in India suffer from diabetes, with an additional 13.6 crore people affected by pre-diabetes. This significant health concern positions India to become the diabetes capital of the world by 2030. In […]

Continue Reading
IPCA Laboratories Ltd

IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India

up18news

Sri. Sunil Ghai, President Marketing, IPCA, Sri. Supreet Deshpande, CEO, NovaLead Pharma Pvt Ltd, IPCA, Sri. Premchand Godha, Chairman,IPCA, Sri. Ajit Jain, Managing Director, IPCA, Dr. Anil Pareek, President Medical affairs, Clinical research and Regulatory affairs. Mumbai (Maharashtra) [India], August 16: As per the ICMR-INDIAB (2023) study, 10 crore people in India suffer from diabetes, […]

Continue Reading